zilganersen

Drug identity checked against registry records

Also recorded as ION373

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD)NCT04849741IONSPhase 3Active not recruiting2025-08-22Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.